ScholarIQanswers from OpenAlex & ORCID
Jan Borén
ResearcherPublications, citations & collaboration network
Jan Borén is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Jan Borén have?
ScholarIQindexed works
Jan Borén has 625 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Jan Borén have?
ScholarIQcitation count
Jan Borén has 49,596 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Jan Borén?
ScholarIQh-index
Jan Borén has an h-index of 104 in OpenAlex.
What is the i10-index of Jan Borén?
ScholarIQi10-index
Jan Borén has an i10-index of 355 in OpenAlex.
What is the ORCID of Jan Borén?
ScholarIQorcid
The ORCID for Jan Borén is on the source record.
What is the OpenAlex record for Jan Borén?
ScholarIQopenalex
The OpenAlex for Jan Borén is on the source record.
What are the most-cited papers on Jan Borén?
ScholarIQmost cited works
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
Brian A. Ference, Henry N. Ginsberg, Ian Graham, Kausik K. Ray, Chris J. Packard, Éric Bruckert, Robert A. Hegele, Ronald M. Krauss, Frederick J. Raal, Heribert Schunkert, Gerald F. Watts, Jan Borén, Sergio Fazio, Jay D. Horton, L. Masana, Stephen J. Nicholls, Børge G. Nordestgaard, Bart van de Sluis, Marja‐Riitta Taskinen, Lâle Tokgözoğlu, Ulf Landmesser, Ulrich Laufs, Olov Wiklund, Jane K. Stock, M. John Chapman, Alberico L. Catapano
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
Børge G. Nordestgaard, M. John Chapman, Steve E. Humphries, Henry N. Ginsberg, L. Masana, Olivier Descamps, Olov Wiklund, Robert A. Hegele, Frederick J. Raal, Joep C. Defesche, Albert Wiegman, Rodrigo da Silva Santos, Gerald F. Watts, KG Parhofer, G. Kees Hovingh, Petri T. Kovanen, Cathérine Boileau, Maurizio Averna, Jan Borén, E. Bruckert, Alberico L. Catapano, Jan Albert Kuivenhoven, P. Pajukanta, Kausik K. Ray, A.F.H. Stalenhoef, Erik S.G. Stroes, Marja‐Riitta Taskinen, Anne Tybjærg‐Hansen, for the European Atherosclerosis Society Consensus Panel
Lipoprotein(a) as a cardiovascular risk factor: current status
Børge G. Nordestgaard, M. John Chapman, Kausik K. Ray, Jan Borén, Felicita Andreotti, Gerald F. Watts, Henry N. Ginsberg, Pierre Amarenco, Alberico L. Catapano, Olivier Descamps, Edward A. Fisher, Petri T. Kovanen, Jan Albert Kuivenhoven, Philippe Lesnik, L. Masana, Željko Reiner, Marja‐Riitta Taskinen, Lâle Tokgözoğlu, Anne Tybjærg‐Hansen
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
Jan Borén, M. John Chapman, Ronald M. Krauss, Chris J. Packard, Jacob Fog Bentzon, Christoph J. Binder, Mat J.A.P. Daemen, Linda L. Demer, Robert A. Hegele, Stephen J. Nicholls, Børge G. Nordestgaard, Gerald F. Watts, Éric Bruckert, Sergio Fazio, Brian A. Ference, Ian Graham, Jay D. Horton, Ulf Landmesser, Ulrich Laufs, L. Masana, Gerard Pasterkamp, Frederick J. Raal, Kausik K. Ray, Heribert Schunkert, Marja‐Riitta Taskinen, Bart van de Sluis, Olov Wiklund, Lâle Tokgözoğlu, Alberico L. Catapano, Henry N. Ginsberg
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
M. John Chapman, Henry N. Ginsberg, Pierre Amarenco, Felicita Andreotti, Jan Borén, Alberico L. Catapano, Olivier Descamps, Edward A. Fisher, Petri T. Kovanen, Jan Albert Kuivenhoven, Philippe Lesnik, L. Masana, Børge G. Nordestgaard, Kausik K. Ray, Željko Reiner, Marja‐Riitta Taskinen, Lâle Tokgözoğlu, Anne Tybjærg‐Hansen, Gerald F. Watts, for the European Atherosclerosis Society Consensus Panel